US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

LivaNova PLC

us-stock
To Invest in {{usstockname}}
us-stock
$63.29 -0.0061(-0.61%) LIVN at 04 Dec 2025 04:37 PM Medical Devices
Lowest Today 62.86
Highest Today 63.98
Today’s Open 63.49
Prev. Close 63.68
52 Week High 64.31
52 Week Low 32.48
Day’s Range: Low 62.86 High 63.98
52-Week Range: Low 32.48 High 64.31
1 day return -
1 Week return -0.59
1 month return +17.42
3 month return +8.88
6 month return +42.3
1 year return +23.83
3 year return +14.93
5 year return +14.62
10 year return -

Institutional Holdings

BlackRock Inc 13.38

PRIMECAP Management Company 8.50

Vanguard Group Inc 4.50

Millennium Management LLC 4.44

State Street Corp 3.81

AQR Capital Management LLC 3.75

Vanguard Capital Opportunity Inv 3.61

iShares Core S&P Mid-Cap ETF 3.25

Dimensional Fund Advisors, Inc. 2.96

Geode Capital Management, LLC 2.62

iShares Russell 2000 ETF 2.42

Wellington Management Company LLP 2.34

Artisan Partners Limited Partnership 2.29

Hotchkis & Wiley Capital Management LLC 2.12

Goldman Sachs Group Inc 2.01

Amvescap Plc. 1.88

Redmile Group, LLC 1.71

Victory Capital Management Inc. 1.68

Invesco Small Cap Value A 1.65

PRIMECAP Odyssey Aggressive Growth 1.62

D. E. Shaw & Co LP 1.59

Artisan International Small-Mid Investor 1.52

Artisan Non-U.S. Small-Mid Growth Comp 1.52

ExodusPoint Capital Management, LP 1.49

Marshall Wace Asset Management Ltd 1.49

Scopia Management Inc 1.49

Nuveen, LLC 1.45

Vanguard PRIMECAP Core Inv 1.19

Fort Washington Small Company Equity 1.11

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Fidelity Small Cap Index 1.00

PRIMECAP Odyssey Growth 0.98

Small Company Equity - FTWA 0.95

Touchstone Small Company A 0.94

Bestinfond FI 0.90

BlackRock Global Equity Mkt Netrl Instl 0.89

iShares Russell 2000 Value ETF 0.88

Bestinver Internacional FI 0.86

SPDR® S&P MIDCAP 400 ETF Trust 0.77

Vanguard Strategic Equity Inv 0.73

Market Status

Strong Buy: 4

Buy: 4

Hold: 3

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 3477.28 M

PB Ratio 2.9784

PE Ratio 0.0

Enterprise Value 3287.17 M

Total Assets 2506.39 M

Volume 554731

Company Financials

Annual Revenue FY24:1253400000 1253.4M, FY23:1118287000 1118.3M, FY22:1021800000 1021.8M, FY21:1035400000 1035.4M, FY20:934200000 934.2M

Annual Profit FY24:870900000 870.9M, FY23:764600000 764.6M, FY22:707200000 707.2M, FY21:706000000 706.0M, FY20:618200000 618.2M

Annual Net worth FY24:63200000 63.2M, FY23:2868000 2.9M, FY22:-86200000 -86.2M, FY21:-135700000 -135.7M, FY20:-343300000 -343.3M

Quarterly Revenue Q3/2025:357800000 357.8M, Q2/2025:352524000 352.5M, Q1/2025:316855000 316.9M, Q4/2024:321800000 321.8M, Q3/2024:318120000 318.1M

Quarterly Profit Q3/2025:244900000 244.9M, Q2/2025:238988000 239.0M, Q1/2025:220775000 220.8M, Q4/2024:219400000 219.4M, Q3/2024:225264000 225.3M

Quarterly Net worth Q3/2025:26800000 26.8M, Q2/2025:27161000 27.2M, Q1/2025:-327322000 -327.3M, Q4/2024:55900000 55.9M, Q3/2024:32953000 33.0M

Fund house & investment objective

Company Information LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Organisation Medical Devices

Employees 2900

Industry Medical Devices

CEO Mr. Vladimir A. Makatsaria

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right